Rhythm Pharmaceuticals, Inc. Made Big Gain
Wed, Sep 14, 2022 at 07:33 PM
Rhythm Pharmaceuticals, Inc. (RYTM:NASDAQ) jumped higher at $30.85, representing a gain of 24.4%. On Wed, Sep 14, 2022, RYTM:NASDAQ hit a New 2-Week High of $30.85. The stock appeared on our News Catalysts scanner on Wed, Sep 14, 2022 at 04:10 PM in the 'PUBLIC OFFERING' category. From Wed, Aug 31, 2022, the stock recorded 44.44% Up Days and 50.00% Green Days
About Rhythm Pharmaceuticals, Inc. (RYTM:NASDAQ)
Rhythm Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders.
Top 10 Gainers:
- AMTD Digital Inc. American Depositary Shares (every five of which represent two Class A) (HKD:NYSE), 311.78%
- Avenue Therapeutics, Inc. (ATXI:NASDAQ), 53.2%
- AMTD International Inc. American Depositary Shares each representing one Class A (AMTD:NYSE), 50%
- Aileron Therapeutics, Inc. (ALRN:NASDAQ), 42.21%
- Dawson Geophysical Company (DWSN:NASDAQ), 40.18%
- Akerna Corp. (KERN:NASDAQ), 26.92%
- Rhythm Pharmaceuticals, Inc. (RYTM:NASDAQ), 24.4%
- SciSparc Ltd. (SPRC:NASDAQ), 23.89%
- ZeroFox Holdings Inc. (ZFOX:NASDAQ), 22.9%
- Magic Empire Global Limited (MEGL:NASDAQ), 21.51%